definiens: shall mean, with respect to the first 1/3 ( one third ) of the options granted to Hadasit and to the Scientists under the Consulting Agreement, that vest in accordance with Section 10.3.1 of the Consulting Agreement, a price per share of US$ 32.02 ( thirty t wo US Dollars and two cents ), reflecting a 20 % ( twenty percent ) discount on the price per share paid by Teva within the framework of the investment round in the Company by Teva, HBL -Hadasit Bio - Holdings Ltd. and BioTime Inc. scheduled to be consummated in October, 2010 ( the ) and with respect to the remaining 2/3 ( two thirds ) of the options granted to Hadasit and to the Scientists under the Consulting Agreement, that vest in accordance with Sections 10.3.2 and 10.3.3 of the Consulting Agreement, a pr ice per share of US$ 40.02 ( forty US Dollars and two cents ), which is the price per share paid in the Round